Search research articles
Contact Us
Filters
Showing results (11-20 of 146) with videos related to
Page
of 15
Sort By:
AIDS (London, England)
|
August 18, 2022
Can simplified antiretroviral drug combination therapies resist resistance?
Brian Conway, Bluma G Brenner
Expert Review of Anti-Infective Therapy
|
October 16, 2004
And now for something completely simple
Brian Conway, Stanley De Vlaming
The Journal of Physical Chemistry. B
|
June 29, 2018
Simulations of 1-Butyl-3-methylimidazolium Tetrafluoroborate + Acetonitrile Mixtures: Force-Field Validation and Frictional Characteristics
Brian Conway, Caleb Uitvlugt, Mark Maroncelli
BMJ Case Reports
|
March 30, 2021
Late presentation of myocardial infarction (MI) during the COVID-19 pandemic
Chidambaram Chinniah, Brian Conway, Neil Yager
BMJ Case Reports
|
February 14, 2020
Glecaprevir/pibrentasvir+sofosbuvir: an optimal retreatment strategy in the setting of HCV NS5A resistance
Arshia Alimohammadi, Brian Conway, Leo Yamamoto
Journal of Virus Eradication
|
January 14, 2025
Long-term outcome in people who use drugs successfully treated for hepatitis C infection with glecaprevir/pibrentasvir
Shana Yi, David Truong, Brian Conway
AIDS (London, England)
|
May 4, 2023
Point-of-care urine tenofovir testing: making a good thing better
Mauro Zaccarelli, Bienvenu Niyongabo, Brian Conway
AIDS (London, England)
|
January 29, 2025
Beyond virologic suppression
Brian Conway, Christina Wiesmann, Krit Pongpirul
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
May 26, 2011
Is there a need for heroin substitution treatment in Vancouver's Downtown Eastside?
Meldon Kahan, Anita Srivastava, Brian Conway
AIDS (London, England)
|
August 4, 2025
Understanding the clinical implications of low-level viremia in ART-treated individuals
Brian Conway, Pablo Tebas, Laurence Slama
Page
of 15
Search research articles
Search
Showing results (11-20 of 146) with videos related to
Sort By:
Page
of 15
AIDS (London, England)
|
August 18, 2022
Can simplified antiretroviral drug combination therapies resist resistance?
Brian Conway, Bluma G Brenner
Expert Review of Anti-Infective Therapy
|
October 16, 2004
And now for something completely simple
Brian Conway, Stanley De Vlaming
The Journal of Physical Chemistry. B
|
June 29, 2018
Simulations of 1-Butyl-3-methylimidazolium Tetrafluoroborate + Acetonitrile Mixtures: Force-Field Validation and Frictional Characteristics
Brian Conway, Caleb Uitvlugt, Mark Maroncelli
BMJ Case Reports
|
March 30, 2021
Late presentation of myocardial infarction (MI) during the COVID-19 pandemic
Chidambaram Chinniah, Brian Conway, Neil Yager
BMJ Case Reports
|
February 14, 2020
Glecaprevir/pibrentasvir+sofosbuvir: an optimal retreatment strategy in the setting of HCV NS5A resistance
Arshia Alimohammadi, Brian Conway, Leo Yamamoto
Journal of Virus Eradication
|
January 14, 2025
Long-term outcome in people who use drugs successfully treated for hepatitis C infection with glecaprevir/pibrentasvir
Shana Yi, David Truong, Brian Conway
AIDS (London, England)
|
May 4, 2023
Point-of-care urine tenofovir testing: making a good thing better
Mauro Zaccarelli, Bienvenu Niyongabo, Brian Conway
AIDS (London, England)
|
January 29, 2025
Beyond virologic suppression
Brian Conway, Christina Wiesmann, Krit Pongpirul
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
May 26, 2011
Is there a need for heroin substitution treatment in Vancouver's Downtown Eastside?
Meldon Kahan, Anita Srivastava, Brian Conway
AIDS (London, England)
|
August 4, 2025
Understanding the clinical implications of low-level viremia in ART-treated individuals
Brian Conway, Pablo Tebas, Laurence Slama
Page
of 15